Department of Statistics, Prasanna School of Public Health, Manipal Academy of Higher Education, Level 6, Health Science Library Building, Madhav Nagar, Manipal, Karnataka, 576104, India.
The Campbell Collaboration, New Delhi, India.
Syst Rev. 2017 Dec 12;6(1):252. doi: 10.1186/s13643-017-0648-7.
Neonatal systemic infections and their consequent impairments give rise to long-lasting health, economic and social effects on the neonate, the family and the nation. Considering the dearth of consolidated economic evidence in this important area, this systematic review aims to critically appraise and consolidate the evidence on economic evaluations of management of neonatal systemic infections in South Asia.
Full and partial economic evaluations, published in English, associated with the management of neonatal systemic infections in South Asia will be included. Any intervention related to management of neonatal systemic infections will be eligible for inclusion. Comparison can include a placebo or alternative standard of care. Interventions without any comparators will also be eligible for inclusion. Outcomes of this review will include measures related to resource use, costs and cost-effectiveness. Electronic searches will be conducted on PubMed, CINAHL, MEDLINE (Ovid), EMBASE, Web of Science, EconLit, the Centre for Reviews and Dissemination Library (CRD) Database, Popline, IndMed, MedKnow, IMSEAR, the Cost Effectiveness Analysis (CEA) Registry and Pediatric Economic Database Evaluation (PEDE). Conference proceedings and grey literature will be searched in addition to performing back referencing of bibliographies of included studies. Two authors will independently screen studies (in title, abstract and full-text stages), extract data and assess risk of bias. A narrative summary and tables will be used to summarize the characteristics and results of included studies.
Neonatal systemic infections can have significant economic repercussions on the families, health care providers and, cumulatively, the nation. Pediatric economic evaluations have focused on the under-five age group, and published consolidated economic evidence for neonates is missing in the developing world context. To the best of our knowledge, this is the first review of economic evidence on neonatal systemic infections in the South Asian context. Further, this protocol provides an underst anding of the methods used to design and evaluate economic evidence for methodological quality, transparency and focus on health equity. This review will also highlight existing gaps in research and identify scope for further research.
PROSPERO CRD42017047275.
新生儿全身感染及其随之而来的损伤会对新生儿、家庭和国家的健康、经济和社会产生持久的影响。考虑到在这一重要领域缺乏综合经济证据,本系统评价旨在批判性地评估和整合南亚新生儿全身感染管理的经济评价证据。
本研究将纳入以英语发表的与南亚新生儿全身感染管理相关的全成本和部分成本经济评价。任何与新生儿全身感染管理相关的干预措施都符合纳入标准。比较可以包括安慰剂或替代标准护理。没有任何对照的干预措施也符合纳入标准。本研究的结果将包括与资源利用、成本和成本效益相关的措施。将在 PubMed、CINAHL、MEDLINE(Ovid)、EMBASE、Web of Science、EconLit、考科蓝中心(CRD)图书馆、Popline、IndMed、MedKnow、IMSEAR、成本效果分析(CEA)登记处和儿科经济数据库评价(PEDE)上进行电子检索。除了对纳入研究的参考文献进行回溯外,还将对会议记录和灰色文献进行检索。两位作者将独立筛选研究(在标题、摘要和全文阶段),提取数据并评估偏倚风险。将使用叙述性总结和表格来总结纳入研究的特征和结果。
新生儿全身感染会对家庭、医疗保健提供者,乃至整个国家产生重大的经济影响。儿科经济学评价主要集中在五岁以下儿童群体,在发展中国家背景下,针对新生儿的已发表综合经济证据缺失。据我们所知,这是首次对南亚地区新生儿全身感染的经济证据进行综述。此外,本方案还提供了对设计和评估经济证据的方法的理解,这些方法侧重于方法学质量、透明度和对健康公平的关注。本综述还将突出研究中的现有差距,并确定进一步研究的范围。
PROSPERO CRD42017047275。